EP1767619A4 - Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor - Google Patents

Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor

Info

Publication number
EP1767619A4
EP1767619A4 EP05745963A EP05745963A EP1767619A4 EP 1767619 A4 EP1767619 A4 EP 1767619A4 EP 05745963 A EP05745963 A EP 05745963A EP 05745963 A EP05745963 A EP 05745963A EP 1767619 A4 EP1767619 A4 EP 1767619A4
Authority
EP
European Patent Office
Prior art keywords
stem cells
embryonic stem
amniotic membrane
culturing embryonic
origin factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05745963A
Other languages
German (de)
French (fr)
Other versions
EP1767619A1 (en
Inventor
Yoshiki Sasai
Morio Ueno
Shigeru Kinoshita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN Institute of Physical and Chemical Research
Original Assignee
RIKEN Institute of Physical and Chemical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN Institute of Physical and Chemical Research filed Critical RIKEN Institute of Physical and Chemical Research
Publication of EP1767619A1 publication Critical patent/EP1767619A1/en
Publication of EP1767619A4 publication Critical patent/EP1767619A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5073—Stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0619—Neurons
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5058—Neurological cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Engineering & Computer Science (AREA)
EP05745963A 2004-05-27 2005-05-27 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor Withdrawn EP1767619A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004158421A JP4576545B2 (en) 2004-05-27 2004-05-27 Embryonic stem cell culture method using amnion-derived factor
PCT/JP2005/010201 WO2005116191A1 (en) 2004-05-27 2005-05-27 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor

Publications (2)

Publication Number Publication Date
EP1767619A1 EP1767619A1 (en) 2007-03-28
EP1767619A4 true EP1767619A4 (en) 2008-07-23

Family

ID=35450886

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05745963A Withdrawn EP1767619A4 (en) 2004-05-27 2005-05-27 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor

Country Status (4)

Country Link
US (1) US7923246B2 (en)
EP (1) EP1767619A4 (en)
JP (1) JP4576545B2 (en)
WO (1) WO2005116191A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008099662A (en) * 2006-09-22 2008-05-01 Institute Of Physical & Chemical Research Method for culturing stem cell
US7892830B2 (en) * 2007-01-17 2011-02-22 Wisconsin Alumni Research Foundation Clonal culture of human pluripotent stem cells
JP5234535B2 (en) * 2007-06-25 2013-07-10 株式会社ニデック Additive for in vitro maturation culture of mammalian immature ovum and method for producing mature ovum using the same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US20140127803A1 (en) * 2011-04-20 2014-05-08 Osaka Univeristy iPS CELL HAVING DIFFERENTIATION PROPENSITY FOR CORNEAL EPITHELIUM
EP2731555B1 (en) 2011-07-13 2018-11-07 Vivex Biomedical, Inc. Spinal implants with stem cells
RU2458984C1 (en) * 2011-07-18 2012-08-20 Российская Федерация, От Имени Которой Выступает Министерство Образования И Науки Российской Федерации Method of producing mammal embryonic stem cells modified with human nerve growth factor gene
CA2986702C (en) 2015-05-21 2023-04-04 David Wang Modified demineralized cortical bone fibers
WO2018043567A1 (en) * 2016-08-31 2018-03-08 国立大学法人京都大学 Compound for removing human pluripotent stem cells
CN111973808A (en) * 2020-09-04 2020-11-24 安徽惠恩生物科技股份有限公司 Biological membrane material adopting cell transplantation as carrier

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302533A1 (en) * 2000-05-16 2003-04-16 Kyowa Hakko Kogyo Co., Ltd. Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5380201A (en) * 2000-04-27 2001-11-07 Ray Jui Fang Tsai Method for expansion of epithelial stem cells
US8273570B2 (en) * 2000-05-16 2012-09-25 Riken Process of inducing differentiation of embryonic cell to cell expressing neural surface marker using OP9 or PA6 cells
WO2003007853A1 (en) * 2000-07-21 2003-01-30 The Spineology Group, Llc An expandable porous mesh bag device and its use for bone surgery
JP4294482B2 (en) * 2001-11-15 2009-07-15 協和発酵キリン株式会社 Differentiation inducer from embryonic stem cells to ectoderm cells, method for obtaining the same, and use thereof
EP1454600B1 (en) * 2001-11-19 2011-08-31 ArBlast Co., Ltd. Ectocornea-like sheet and method of constructing the same
US20050214259A1 (en) * 2002-04-30 2005-09-29 Yoichiro Sano Corneal endothelium-like sheet and method of constructing the same
JP2004024852A (en) * 2002-04-30 2004-01-29 Amniotec:Kk Cornea endothelium-like sheet and manufacturing method therefor
JP2005137337A (en) * 2003-03-07 2005-06-02 Kanji Miyamoto Cell cultivation and cultured cell

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1302533A1 (en) * 2000-05-16 2003-04-16 Kyowa Hakko Kogyo Co., Ltd. Novel method of inducing the differentiation of embryonic stem cells into ectodermal cells and use thereof

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
KOIZUMI N J ET AL: "Growth factor mRNA and protein in preserved human amniotic membrane.", CURRENT EYE RESEARCH MAR 2000, vol. 20, no. 3, March 2000 (2000-03-01), pages 173 - 177, XP009084186, ISSN: 0271-3683 *
SCHULDINER MAYA ET AL: "Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 97, no. 21, 10 October 2000 (2000-10-10), pages 11307 - 11312, XP002184277, ISSN: 0027-8424 *
See also references of WO2005116191A1 *
UENO MORIO ET AL: "Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 103, no. 25, June 2006 (2006-06-01), pages 9554 - 9559, XP002435168, ISSN: 0027-8424 *
XU CHUNHUI ET AL: "Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium", STEM CELLS, ALPHAMED PRESS, DAYTON, OH, US, vol. 23, no. 3, March 2005 (2005-03-01), pages 315 - 323, XP002409422, ISSN: 1066-5099 *
ZHANG S-C ET AL: "In vitro differentiation of transplantable neural precursors from human embryonic stem cells", NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 19, no. 12, December 2001 (2001-12-01), pages 1129 - 1133, XP002268706, ISSN: 1087-0156 *

Also Published As

Publication number Publication date
US7923246B2 (en) 2011-04-12
EP1767619A1 (en) 2007-03-28
US20070178587A1 (en) 2007-08-02
JP4576545B2 (en) 2010-11-10
JP2005333904A (en) 2005-12-08
WO2005116191A1 (en) 2005-12-08

Similar Documents

Publication Publication Date Title
EP1767619A4 (en) Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor
GB0706625D0 (en) Culturing human embryonic stem cells
GB0716313D0 (en) Methods for embryonic stem cell culture
EP1812554A4 (en) Derivation of embryonic stem cells
HK1207883A1 (en) Cell culture method and utilization of the same
GB2428044B (en) Method of forming mesenchymal stem cells from embryonic stem cells
GB2441488B (en) Suspension culture of human embryonic stem cells
GB2431165B (en) Medium for growing human embryonic stem cells
GB2433943B (en) Cultivation of primate embryonic stem cells
IL178232A0 (en) Methods for growing pluripotent stem cells
EP2155859A4 (en) Formulations and methods for culturing embryonic stem cells
IL189882A0 (en) Method of deriving mesenchymal stem cells
EP1730261A4 (en) Compositions and methods for growth of embryonic stem cells
EP1726640A4 (en) Rat embryonic stem cell
PL2046946T3 (en) Pluripotent stem cell culture
GB2429211B (en) Feeder independent extended culture of embryonic stem cells
EP1988152A4 (en) Cell culture construct, cell culture container, construct having spheroid, container having spheroid and method of producing the same
EP2014763A4 (en) Cell culture container and method of producing the same
IL187352A0 (en) Establishment of a human embryonic stem cell line using mammalian cells
EP2348099A4 (en) Temperature-responsive cell culture substrate and method for producing the same
GB0525579D0 (en) Cell culture vessel
EP1735429A4 (en) Methods and compositions for obtaining hematopoietic stem cells derived from embryonic stem cells and uses thereof
GB0517382D0 (en) Cell culture
EP1802744A4 (en) Method for maintaining pluripotency of stem/progenitor cells
EP2029724A4 (en) Derivation of embryonic stem cells and embryo-derived cells

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20061227

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C12N 5/06 20060101AFI20051214BHEP

Ipc: A61P 25/00 20060101ALI20080612BHEP

Ipc: A61P 9/10 20060101ALI20080612BHEP

Ipc: A61P 25/08 20060101ALI20080612BHEP

Ipc: C12Q 1/02 20060101ALI20080612BHEP

Ipc: A61P 25/14 20060101ALI20080612BHEP

Ipc: A61K 35/12 20060101ALI20080612BHEP

Ipc: A61P 25/28 20060101ALI20080612BHEP

Ipc: A61P 25/16 20060101ALI20080612BHEP

Ipc: A61P 21/00 20060101ALI20080612BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20080624

17Q First examination report despatched

Effective date: 20090514

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130405